These findings imply that METTL7B helps cancer cells in evading natural anti-tumor immune responses by decreasing the activity of NK or CTL cells, enhancing suppressive cells (Tregs, TAMs, and neutrophils), and increasing immunosuppressive molecular factors. This evidence concerns the gene TMT1B and neoplasm.